Brain Stimulation (Jul 2022)

Non-invasive optogenetics with ultrasound-mediated gene delivery and red-light excitation

  • Antonios N. Pouliopoulos,
  • Maria F. Murillo,
  • Rebecca Lynn Noel,
  • Alec J. Batts,
  • Robin Ji,
  • Nancy Kwon,
  • Han Yu,
  • Chi-Kun Tong,
  • Jennifer N. Gelinas,
  • Dion Khodagholy Araghy,
  • S. Abid Hussaini,
  • Elisa E. Konofagou

Journal volume & issue
Vol. 15, no. 4
pp. 927 – 941

Abstract

Read online

Optogenetics has revolutionized the capability of controlling genetically modified neurons in vitro and in vivo and has become an indispensable neuroscience tool. Using light as a probe for selective neuronal activation or inhibition and as a means to read out neural activity has dramatically enhanced our understanding of complex neural circuits. However, a common limitation of optogenetic studies to date is their invasiveness and spatiotemporal range. Direct viral injections into the brain tissue along with implantation of optical fibers and recording electrodes can disrupt the neuronal circuitry and cause significant damage. Conventional approaches are spatially limited around the site of the direct injection and insufficient in examining large networks throughout the brain. Lastly, optogenetics is currently not easily scalable to large animals or humans. Here, we demonstrate that optogenetic excitation can be achieved entirely non-invasively through the intact skull in mice. Using a needle-free combination of focused ultrasound-mediated viral delivery and extracorporeal illumination with red light, we achieved selective neuronal activation at depths up to 4 mm in the murine brain, confirmed through cFos expression and electrophysiology measurements within the treated areas. Ultrasound treatment significantly reduced freezing time during recall in fear conditioning experiments, but remote light exposure had a moderate effect on the freezing behavior of mice treated with viral vectors. The proposed method has the potential to open new avenues of studying, but also stimulating, neuronal networks, in an effort to elucidate normal or dysfunctional brain activity and treat neurological diseases. Finally, the same non-invasive methodology could be combined with gene therapy and applied to other organs, such as the eye and the heart.